Cencora Projects 4-6% Revenue Growth for 2026
COR sits 25% above its 52-week low of $244.82.
Summary
Cencora guided for 4% to 6% revenue growth in fiscal 2026, a new disclosure that adds top-line context to the raised EPS guidance from May. The range suggests steady expansion but no major acceleration, consistent with the company's recent acquisition-driven growth. This follows the May 21 EPS raise to $17.70-$17.90 and the $2B buyback authorization, reinforcing a stable outlook. The FTC's intensified review of the Covetrus-MWI Animal Health merger remains a key risk to monitor.
At the time of this announcement, COR was trading at $307.02 on NYSE in the Trade & Services sector, with a market capitalization of approximately $59.6B. The 52-week trading range was $244.82 to $377.54. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.